ESCRS 2023: Presbyopia treatment with microporation therapeutic technology by Ace Vision Group
AnnMarie Hipsley, DPT, PhD, Founder and CEO of Ace Vision Group, met with Ophthalmology Times Europe at the 2023 European Society of Cataract and Refractive Surgeons to discuss Ace Vision Group’s microporation therapeutic technology, used to treat presbyopia.
Explore More Articles
Unlocking the recovery of dynamic range of focus with microporation therapeutics
Laser Scleral Microporation (LSM) is a therapy which represents the first biomechanical solution to the biomechanical problems of progressive presbyopia. The therapy is performed using the VisioLite® Ophthalmic Laser system developed by Ace Vision Group (AVG). Today, having no biomechanical option able to meet the loss of dynamic range of focus (DRoF) that occurs with progressive …
read moreVIDEO: New laser offers further improvement to laser scleral microporation
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, AnnMarie Hipsley, DPT, PhD, and George O. Waring IV, MD, FACS, discuss the latest advances in laser scleral microporation.Hipsley said that the GenII VisioLite laser for laser scleral microporation (LSM) is on the pathway to commercialization and may be available by the end of the year.
read moreData show higher patient expectations for presbyopia laser therapy among women
MARCO ISLAND, Fla. — In this Healio Video Perspective, AnnMarie Hipsley, DPT, PhD, discusses data that compared the patient-reported satisfaction levels of women and men with presbyopia after laser scleral microporation therapy. “Interestingly enough, we had more women than men, about twice as many women in the study, and women were more demanding with their satisfaction than men,” …
read more